Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash Flows from Operating Activities
Net Income	$ 17,347	$ 9,856
Non-cash items included in net income
Depreciation and amortization	7,295	7,632
Deferred income taxes	59	26
Deferred compensation plan	1,530	3,089
Stock compensation expense	2,308	2,466
Employee Stock Purchase Plan Discount	97	0
Issuance of common shares as compensation	270	225
Loss on disposition of fixed assets	37	57
Allowance for doubtful accounts	(80)	205
Inventory obsolescence reserve	740	752
Changes in certain assets and liabilities
Accounts receivable	8,542	(16,104)
Inventories	6,020	(20,175)
Refundable income taxes	(1,865)	247
Accounts payable	(10,034)	5,695
Accrued expenses and other	2,830	(3,708)
Customer prepayments	(2,548)	(2,931)
Net cash flows provided by (used in) operating activities	32,548	(12,668)
Cash Flows from Investing Activities
Purchases of property, plant and equipment	(1,754)	(1,276)
Adjustment to JSI acquisition purchase price	0	500
Proceeds from the sale of fixed assets	1	0
Net cash flows (used in) investing activities	(1,753)	(776)
Cash Flows from Financing Activities
Payments of long-term debt	(150,547)	(113,195)
Borrowings of long-term debt	120,524	130,006
Cash dividends paid	(4,065)	(3,989)
Shares withheld for employees' taxes	(844)	(250)
Payments on financing lease obligations	(192)	(196)
Proceeds from stock option exercises	3,139	26
Net cash flows (used in) provided by financing activities	(31,985)	12,402
Change related to foreign currency	78	8
(Decrease) in cash and cash equivalents	(1,112)	(1,034)
Cash and cash equivalents at beginning of period	2,462	2,282
Cash and cash equivalents at end of period	$ 1,350	$ 1,248